SEC 13F Intelligence

BIORA THERAPEUTICS INC

CUSIP 74319FAB3

Biora Therapeutics Inc has 7 institutional holders in Filings Flow’s 13F database, together reporting 128.53M shares worth $59M as of Q4 2022. The largest reported holders are Context Capital Management, LLC, Silverback Asset Management LLC, and Concourse Financial Group Securities, Inc..

Institutional Holders
7
Q4 2022
Reported Value
$59M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2

Ownership Trend

Institutional holders
Q4 ’21: 6Q4 ’21Q4 ’22: 7Q4 ’22filingsflow.com
Total reported value
Q4 ’21: $94MQ4 ’21Q4 ’22: $59MQ4 ’22filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
Context Capital Management, LLC$4.3B AUM0.22%$3M5.63MQ4 2023OLDER
SILVERBACK ASSET MANAGEMENT LLC$699M AUM0.20%$2M2.60MQ3 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.